Atlas Trials

Study of the Combination of CM082 With JS001 in Patients With Advanced Mucosal Melanoma.

Clinical trial NCT03602547 · UNKNOWN

Trial details

NCT number
NCT03602547
Sponsor
AnewPharma
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Mucosal Melanoma
Start date
2018-07-31
Primary completion
2019-07-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.